Allmed Solutions Ltd (ALMD.TA)
ILA 36.8
(-0.54%)
ILA 36.8
(-0.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.19 Million ILS | -16.21% |
| 2022 | 3.81 Million ILS | 53.56% |
| 2021 | 2.48 Million ILS | -67.27% |
| 2020 | 7.58 Million ILS | -28.59% |
| 2019 | 10.62 Million ILS | 3.6% |
| 2018 | 10.25 Million ILS | -21.69% |
| 2017 | 13.09 Million ILS | -6.64% |
| 2016 | 14.02 Million ILS | 18.61% |
| 2015 | 11.82 Million ILS | -6.78% |
| 2014 | 12.68 Million ILS | -5.2% |
| 2013 | 13.38 Million ILS | 1.12% |
| 2012 | 13.23 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.93 Million ILS | -8.04% |
| 2024 Q2 | 2.93 Million ILS | 0.0% |
| 2023 Q1 | 3.11 Million ILS | -18.33% |
| 2023 Q2 | 3.11 Million ILS | 0.0% |
| 2023 Q4 | 3.19 Million ILS | 0.0% |
| 2023 Q3 | 3.19 Million ILS | 2.6% |
| 2023 FY | 3.19 Million ILS | -16.21% |
| 2022 Q4 | 3.81 Million ILS | 0.0% |
| 2022 Q2 | 2.76 Million ILS | 0.0% |
| 2022 Q1 | 2.76 Million ILS | 11.36% |
| 2022 Q3 | 3.81 Million ILS | 37.9% |
| 2022 FY | 3.81 Million ILS | 53.56% |
| 2021 Q1 | 6.05 Million ILS | -20.19% |
| 2021 Q2 | 6.05 Million ILS | 0.0% |
| 2021 Q4 | 2.48 Million ILS | 0.0% |
| 2021 Q3 | 2.48 Million ILS | -58.99% |
| 2021 FY | 2.48 Million ILS | -67.27% |
| 2020 FY | 7.58 Million ILS | -28.59% |
| 2020 Q2 | 8.73 Million ILS | 0.0% |
| 2020 Q3 | 7.58 Million ILS | -13.09% |
| 2020 Q4 | 7.58 Million ILS | 0.0% |
| 2020 Q1 | 8.73 Million ILS | -17.84% |
| 2019 Q3 | 10.62 Million ILS | -22.05% |
| 2019 Q2 | 13.63 Million ILS | 0.0% |
| 2019 FY | 10.62 Million ILS | 3.6% |
| 2019 Q4 | 10.62 Million ILS | 0.0% |
| 2019 Q1 | 13.63 Million ILS | 32.91% |
| 2018 Q3 | 6.52 Million ILS | -51.93% |
| 2018 Q1 | 12.1 Million ILS | -7.59% |
| 2018 FY | 10.25 Million ILS | -21.69% |
| 2018 Q4 | 10.25 Million ILS | 57.28% |
| 2018 Q2 | 13.56 Million ILS | 12.11% |
| 2017 Q4 | 13.09 Million ILS | 9.48% |
| 2017 FY | 13.09 Million ILS | -6.64% |
| 2017 Q1 | 13.09 Million ILS | -6.66% |
| 2017 Q2 | 14.23 Million ILS | 8.68% |
| 2017 Q3 | 11.96 Million ILS | -15.94% |
| 2016 Q2 | 6.13 Million ILS | 9.88% |
| 2016 FY | 14.02 Million ILS | 18.61% |
| 2016 Q3 | 6.42 Million ILS | 4.68% |
| 2016 Q4 | 14.02 Million ILS | 118.33% |
| 2016 Q1 | 5.58 Million ILS | -0.6% |
| 2015 FY | 11.82 Million ILS | -6.78% |
| 2015 Q4 | 5.62 Million ILS | 0.84% |
| 2015 Q3 | 5.57 Million ILS | -20.86% |
| 2015 Q2 | 7.04 Million ILS | -10.8% |
| 2015 Q1 | 7.89 Million ILS | 42.0% |
| 2014 FY | 12.68 Million ILS | -5.2% |
| 2014 Q4 | 5.56 Million ILS | -7.58% |
| 2014 Q3 | 6.01 Million ILS | -3.54% |
| 2014 Q2 | 6.23 Million ILS | -0.37% |
| 2014 Q1 | 6.26 Million ILS | -3.88% |
| 2013 Q2 | 4.43 Million ILS | -20.43% |
| 2013 FY | 13.38 Million ILS | 1.12% |
| 2013 Q4 | 6.51 Million ILS | 41.86% |
| 2013 Q1 | 5.57 Million ILS | -57.88% |
| 2013 Q3 | 4.59 Million ILS | 3.49% |
| 2012 FY | 13.23 Million ILS | 0.0% |
| 2012 Q3 | 4.2 Million ILS | 0.0% |
| 2012 Q4 | 13.23 Million ILS | 214.52% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|